CURLF - Curaleaf Holdings, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Curaleaf Holdings, Inc.

301 Edgewater Place
Suite 405
Wakefield, MA 01880
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees1,073

Key Executives

NameTitlePayExercisedYear Born
Mr. Boris Alexis JordanExec. ChairmanN/AN/A1966
Mr. Joseph LusardiPres, CEO & DirectorN/AN/A1974
Mr. Neil P. Davidson CPACFO & TreasurerN/AN/A1972
Mr. Stuart Anthony WilcoxChief Operating OfficerN/AN/A1961
Mr. Daniel P. FoleyVP of Fin. & Investor RelationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products, such as vape oils and concentrates; flower, pre-rolls, and flower pods; topical lotions; capsules and tinctures; mints and lozenges; and edibles. The company also provides hemp-based CBD products. As of September 18, 2019, it operated 49 dispensaries, 14 cultivation sites, and 13 processing sites in 12 states. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Corporate Governance

Curaleaf Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.